\n<\/p>\n
\n Rigorous planning and testing to ensure supply chain supports vaccine\u2019s stringent temperature requirements <\/p>\n
TOKYO, JAPAN\u00a0<\/span>–<\/span>\u00a0<\/span>Media OutReach<\/span><\/a><\/span>\u00a0<\/span>– 16\u00a0<\/span>February 2021\u00a0<\/span>–<\/span>\u00a0<\/span><\/span>DHL, the
“We are proud to play a role in helping the people of Japan
To safely store the
\u00a0<\/span><\/p>\n
Charles Kaufmann, CEO, North Asia & South Pacific, DHL
\u00a0<\/span><\/p>\n
Across the globe, DHL has been entrusted with the shipments
\u00a0<\/span><\/p>\n
DHL’s portfolio for the life
\nleading global brand in the logistics industry today announced the successful
\ndelivery of the first shipment of COVID-19 vaccines on a cargo flight from
\nBelgium to Japan. The first of numerous shipments that will be delivered
\nthroughout the year, the vaccines were packed with sophisticated GPS and
\ntemperature trackers in each thermal shipper box to provide full visibility
\nthroughout the shipment’s entire journey. DHL Global Forwarding also handled
\nthe customs clearance in Japan, and will dispatch the vaccines to vaccination
\nfacilities across Japan. <\/span>
\n
<\/p>\n
\nreceive their vaccinations for COVID-19, which has upended lives and businesses
\nhere. While DHL Global Forwarding’s well-established cold-chain network and
\npharmaceutical logistics expertise were key to the success of the shipment, our
\ndedicated employees were the true unsung heroes who meticulously planned every
\nlast detail to manage an extremely complex operation seamlessly,” said Kelvin
\nLeung, CEO DHL Global Forwarding Asia Pacific.<\/span><\/p>\n
\n
<\/p>\n
\nvaccines at -70 degrees until the final domestic delivery, freezers were
\ninstalled at the storage facility, where additional workers have been employed
\nto support the operations.<\/span> <\/span>
\n
<\/p>\n
\n
<\/p>\n
\nGlobal Forwarding and President\/ Representative Director, DHL Global Forwarding
\nJapan K.K. added, “We have more than 9,000 life science and healthcare specialists
\nacross our global network. Over the past few months, <\/span>our specialist teams in Japan, together with our global
\ncounterparts have spent countless hours <\/span>planning,
\nstrategizing and stress-testing our network and infrastructure <\/span>to ensure we have the capability to move vaccines safely in
\naccordance with the strictest requirements.”\u00a0<\/span><\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nof COVID-19 vaccines to <\/span>Singapore<\/span><\/a>, <\/span>Israel<\/span><\/a>, and <\/span>European
\ncountries<\/span><\/a> including Austria, Bulgaria, Croatia, Greece, Finland,
\nItaly, Lithuania, Norway, Romania and Sweden.<\/span><\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nscience and healthcare industry includes 150+ pharmacists, 20+ clinical trials
\ndepots, 100+ certified stations, 160+ GDP-qualified warehouses, 15+
\nGMP-certified sites, 135+ medical express sites, and a time-definite
\ninternational express network covering 220 countries and territories.<\/span><\/p>\n
\nGlobally, logistics providers are challenged to establish medical supply chains rapidly to deliver vaccines of
\nunprecedented amount of more than 10 billion doses worldwide, including in
\nregions with less developed logistics infrastructure<\/span>, where
\napproximately three billion people live. To provide global coverage <\/span>over the next two years, DHL estimated in
\nits vaccine <\/span>whitepaper<\/span><\/a><\/span> report that up to 200,000 pallet shippers and 15 million
\ncooling boxes as well as 15,000 flights will be required <\/span>across the
\nvarious supply chain setups.<\/span><\/p>\n